Pfizer Inc. pulled off a comeback win, beating out Danish drug giant Novo Nordisk to acquire obesity drug developer Metsera Inc. in a deal that values the biotechnology company at up to $9.1 billion.
When you buy through our links, Business Insider may earn an affiliate commission. Learn more You don't have to spend a fortune to find the perfect gift — it really is the thoughts that counts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback